Patents by Inventor Semi Lim

Semi Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for screening anticancer agent inhibiting binding of AIMP2-DX2 and HSP70
    Patent number: 11442057
    Abstract: The present invention relates to a method for screening an anticancer agent which inhibits the binding of AIMP2-DX2 and HSP70. In addition, the pharmaceutical composition for preventing or treating cancer comprising, as an active ingredient, an anticancer agent screened according to the method of the present invention inhibits the expression of HSP70 or inhibits the binding of HSP70 and AIMP2-DX2, thereby lowering the level of AIMP2-DX2 protein, and can effectively prevent the progression of cancer. As such, the pharmaceutical composition can be useful for developing a cancer treating agent.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: September 13, 2022
    Assignee: MEDICINAL BIOCONVERGENCE RESEARCH CENTER
    Inventors: Sunghoon Kim, Dae Gyu Kim, Semi Lim
  • METHOD FOR SCREENING ANTICANCER AGENT INHIBITING BINDING OF AIMP2-DX2 AND HSP70
    Publication number: 20190033295
    Abstract: The present invention relates to a method for screening an anticancer agent which inhibits the binding of AIMP2-DX2 and HSP70. In addition, the pharmaceutical composition for preventing or treating cancer comprising, as an active ingredient, an anticancer agent screened according to the method of the present invention inhibits the expression of HSP70 or inhibits the binding of HSP70 and AIMP2-DX2, thereby lowering the level of AIMP2-DX2 protein, and can effectively prevent the progression of cancer. As such, the pharmaceutical composition can be useful for developing a cancer treating agent.
    Type: Application
    Filed: September 7, 2018
    Publication date: January 31, 2019
    Inventors: Sunghoon Kim, Dae Gyu Kim, Semi Lim